Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors-Reference-Cited by-同舟云学术

Restoration of the insulinotropic effect of glucose-dependent insulinotropic polypeptide contributes to the antidiabetic effect of dipeptidyl peptidase-4 inhibitors

Published:2014-10-26 Issue:1 Volume:17 Page:74-81
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Aaboe K.¹,Akram S.¹,Deacon C. F.²,Holst J. J.²,Madsbad S.³,Krarup T.¹

Affiliation:

1. Department of Endocrinology I; Bispebjerg Hospital, University of Copenhagen; Copenhagen Denmark

2. The NNF Center for Basic Metabolic Research, Department of Biomedical Sciences; Panum Institute, University of Copenhagen; Copenhagen Denmark

3. Department of Endocrinology; Hvidovre Hospital, University of Copenhagen; Copenhagen Denmark

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/dom.12395/fullpdf

Reference33 articles.

1. Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects;Vilsbøll;Regul Pept,2003

2. Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes;Højberg;Diabetologia,2009

3. The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects;Kjems;Diabetes,2003

4. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype;Vilsbøll;J Clin Endocrinol Metab,2003

5. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus;Nauck;J Clin Invest,1993

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

2. Safety of native glucose-dependent insulinotropic polypeptide in humans;Peptides;2024-07

3. Gastric emptying in newly diagnosed, treatment‐naïve Han Chinese with type 2 diabetes and the impact of 4‐week insulin pump therapy;Diabetes, Obesity and Metabolism;2024-05-02

4. Duodenal enteroendocrine cells and GIP as treatment targets for obesity and type 2 diabetes;Peptides;2024-04

5. Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery;Journal of Controlled Release;2023-11